TTD | Drug: D04AHQ

Drug General Information
Drug ID	D04AHQ
Former ID	DIB005975
Drug Name	LY3009120
Indication	Cancer [ICD9: 140-229; ICD10:C00-C96]		Phase 1	[524570]
Company	Lilly
Target and Pathway
Target(s)	Raf protein kinase	Target Info	Modulator
References
Ref 524570	ClinicalTrials.gov (NCT02014116) A Study of LY3009120 in Participants With Advanced Cancer or Cancer That Has Spread to Other Parts of Their Body. U.S. National Institutes of Health.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.

Drug Information